Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

The US data suggest that the South has seen the greatest shifts, and the highest rate of GLP-1 prescribing per capita.

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

That’s according to an analysis by Real Chemistry, a healthcare marketing firm that looked at spending and variations in the ...

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...

Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...